论文部分内容阅读
目的:观察丙酸氟替卡松治疗支气管哮喘中度发作的疗效及安全性。方法:选取支气管哮喘中度发作患者120例,随机分为丙酸氟替卡松治疗组和沙丁胺醇对照组,每组各60例,观察两组起效时间、达效高峰时间及疗程结束后的综合疗效。结果:在维持时间及综合疗效判断上,丙酸氟替卡松明显优于沙丁胺醇气雾剂。结论:丙酸氟替卡松对支气管哮喘的长期疗效明显优于沙丁胺醇气雾剂。
Objective: To observe the efficacy and safety of fluticasone propionate in the treatment of moderate attack of bronchial asthma. Methods: One hundred and twenty patients with moderate exacerbation of bronchial asthma were randomly divided into fluticasone propionate treatment group and salbutamol control group, with 60 cases in each group. The onset time, peak effect time and the combined effect after the treatment were observed. RESULTS: Fluticasone propionate was significantly superior to salbutamol aerosol in maintaining time and judging its overall efficacy. Conclusion: The long-term efficacy of fluticasone propionate on bronchial asthma is superior to salbutamol aerosol.